D33.3
Conditions
Interventions
Group 1: All patients that have been diagnosed or treated with vestibular schwannoma (VS) at university hospital Freiburg since 2008.
Excluded were:
- all patients with neurofibromatosis type II
- pat
Sponsors
Universitätsklinikum Freiburg, Klinik für Hals-, Nasen- und Ohrenheilkunde
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: MR image in T1 present vestibular schwannoma has been diagnosed
Exclusion criteria
Exclusion criteria: postoperative patients patients with neurofibomatosis type II no sufficient information about the patient available
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average Dice-Score of DNP-segmentation and manual segmentation. Correlation of symptoms (occurrence and intensity) with DNP-segmentated volume of vestibular schwannoma. Is a larger volume of an acoustic neuroma associated with a higher frequency or greater intensity of symptoms such as hearing loss, vertigo and tinnitus? | — |
Secondary
| Measure | Time frame |
|---|---|
| Which frequency is most affected by hearing loss by the growth of an acoustic neuroma? How strongly does the segmented AN volume correlate with the results of brainstem evoked response audiometry? Can automated segmentation of vestibular schwannoma give us information about the likelihood of occurence and intensity of symptoms? How ist growth of acoustic neuroma ifluenced by stereotaktic radiotherapie? Do Gender, Age or side of the AN korrelate with size and growth rate of AN? | — |
Countries
Germany
Contacts
Public ContactAnn-Kathrin Rauch
Universitätsklinikum Freiburg, Klinik für Hals-, Nasen- und Ohrenheilkunde
Outcome results
None listed